|
|
Yoga for women with breast cancer undergoing radiotherapy
|
5R01CA138800-02
|
$248,158
|
$248,158
|
Cohen, Lorenzo
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S1
|
$35,000
|
$4,200
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S2
|
$5,000
|
$600
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
$215,427
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$817,733
|
$122,659
|
Gonzalez, Frank
|
CCR (NCI)
|
|
|
X-ray Targeted Therapeutic Genes within Nanoparticles
|
5R01CA125757-06
|
$302,750
|
$151,375
|
Hallahan, Dennis
|
WASHINGTON UNIVERSITY
|
|
|
Wwox and Fhit loss and the DNA damage response in breast cancer subtypes
|
5R01CA120516-06
|
$159,760
|
$159,760
|
HUEBNER, KAY
|
OHIO STATE UNIVERSITY
|
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-14
|
$330,937
|
$62,878
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Wound Response Genes in Cancer Progression
|
5R01CA118750-05
|
$289,676
|
$289,676
|
CHANG, HOWARD
|
STANFORD UNIVERSITY
|
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-20
|
$1,808,081
|
$361,616
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Wnt5a and TGF-beta in mammary development and cancer
|
5R01CA126942-03
|
$291,849
|
$291,849
|
Serra, Rosa
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Wnt10b's Functional Role on Mammary Stem Cells
|
5K22CA137168-03
|
$187,920
|
$187,920
|
Miranda-Carboni, Gustavo
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Wnt co-receptor LRP6 turnover and cancer
|
3R01CA124531-04S1
|
$126,911
|
$126,911
|
LI, YONGHE
|
SOUTHERN RESEARCH INSTITUTE
|
|
|
Wnt co-receptor LRP6 turnover and cancer
|
5R01CA124531-04
|
$414,371
|
$414,371
|
LI, YONGHE
|
SOUTHERN RESEARCH INSTITUTE
|
|
|
Wky Rat Genetic Model for Breast Cancer Susceptibility
|
4R01CA077494-13
|
$309,738
|
$309,738
|
GOULD, MICHAEL
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
WISER Sister
|
5R01CA131333-04
|
$627,020
|
$627,020
|
SCHMITZ, KATHRYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Whole Genome Association Study of Mammographic Density
|
5R01CA131332-03
|
$541,359
|
$541,359
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?
|
5R01CA127617-04
|
$623,747
|
$623,747
|
Mandelblatt, Jeanne
|
GEORGETOWN UNIVERSITY
|
|
|
Wavefront Corrected Multimodal Optical Coherence and Two-Photon Microscopy for Ra
|
1F32CA165484-01
|
$48,398
|
$48,398
|
Tao, Yuankai
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-11
|
$1,765,050
|
$88,253
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
|
Walking Forward - American Indian Participation in Cancer Clinical Trials
|
3U54CA142157-03S1
|
$139,968
|
$34,992
|
PETEREIT, DANIEL
|
RAPID CITY REGIONAL HOSPITAL
|
|
|
Walking Forward - American Indian Participation in Cancer Clinical Trials
|
5U54CA142157-03
|
$932,394
|
$233,099
|
PETEREIT, DANIEL
|
RAPID CITY REGIONAL HOSPITAL
|
|
|
Vitamin D3 Effects on Musculoskeletal Symptoms with Use of Aromatase Inhibitors
|
1R21CA149934-01A1
|
$278,628
|
$278,628
|
Shapiro, Alice
|
PARK NICOLLET INSTITUTE
|
|
|
Vitamin D, Related Genes and Breast Cancer Risk
|
5R01CA098661-08
|
$988,767
|
$988,767
|
ZELENIUCH-JACQUOTTE, ANNE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Vitamin D status, Gene Polymorphism and Breast Cancer Progression/Prognosis
|
1R03CA156648-01
|
$290
|
$290
|
Dorjgochoo, Tsogzolmaa
|
VANDERBILT UNIVERSITY
|
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-03
|
$2,728,080
|
$545,616
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Vitamin D and Breast Cancer Biomarkers
|
5R21CA137650-02
|
$300,370
|
$300,370
|
WOOD, MARIE
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
|
Virus-Like Particle Based Antigen Display as Multi-component Anticancer Vaccines
|
1R01CA149451-01A1
|
$501,816
|
$250,908
|
HUANG, XUEFEI
|
MICHIGAN STATE UNIVERSITY
|
|
|
Virtual Clinical Trials: Simulation of Digital Breast Tomosynthesis Screening
|
1R01CA154444-01
|
$630,308
|
$630,308
|
MAIDMENT, ANDREW
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$199,395
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Videoconference CBT for Rural Breast Cancer Survivors with Cognitive Complaints
|
1R21CA143619-01A1
|
|
$0
|
Ferguson, Robert
|
EASTERN MAINE MEDICAL CENTER
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$48,591
|
$2,430
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
|
Vermont PROSPR Research Center (VPRC)
|
1U54CA163303-01
|
$1,293,911
|
$1,293,911
|
GELLER, BERTA
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
|
Vermont Breast Cancer Surveillance System
|
3U01CA070013-15S4
|
$89,673
|
$89,673
|
GELLER, BERTA
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
|
VEGFs in tumor lymphatic metastasis
|
4R01CA142262-03
|
$453,456
|
$136,037
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
VEGF Gene Amplification/Haplotype as Biomarkers for Bevacizumab in Breast Cancer
|
1R01CA155311-01A1
|
$336,052
|
$336,052
|
Schneider, Bryan
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
5R37CA050286-23
|
$460,615
|
$152,003
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-21S1
|
$50,000
|
$17,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-21
|
$490,679
|
$166,831
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$854,488
|
$213,621
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-04
|
$1,200,072
|
$120,007
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
|
Validation of Medicare Claims Data for Mammography
|
1R21CA158510-01
|
$218,198
|
$218,198
|
Fenton, Joshua
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
Validating Cancer Risk Models: a Pilot Study to Evaluate Cost-efficient Methods
|
5R03CA150136-02
|
$80,078
|
$40,039
|
Whittemore, Alice
|
STANFORD UNIVERSITY
|
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$230,674
|
$23,067
|
Hodge, James
|
CCR (NCI)
|
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$269,119
|
$53,823
|
Hodge, James
|
CCR (NCI)
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$20,992
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$39,179
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$1,275,597
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UV/Vit D in radiologic technologists
|
ZIA CP010133-10416
|
$173,051
|
$25,958
|
Freedman, Daryl
|
DCEG (NCI)
|
|
|
UV-Dosimetry
|
ZIA CP010135-10262
|
$101,099
|
$40,439
|
Linet, Martha
|
DCEG (NCI)
|
|
Total relevant funding to Breast for this search: $625,059,909
|
